Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy

Late-stage gastric adenocarcinoma patients have a poor prognosis because of high recurrence rates. To improve long-term outcomes, perioperative chemotherapies are combined with surgery. Human epidermal growth factor receptor 2 (HER2) overexpression had been noted in gastric cancer; therefore, trastu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dong, Cai-Xia, Fu, Jian-Fei, Ye, Xian-Yun, Li, Xiao-Fen, Zhong, Xian, Yuan, Ying
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2014
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161824/
https://ncbi.nlm.nih.gov/pubmed/25232273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i34.12355
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados